Evidence map›Paper›PMID 25941936›Full record

ArticleInternational journal of molecular sciences2015

Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.

Soo Jin Min, Ji Ye Lim, Haeng Ran Kim, Se-Jae Kim, Yuri Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. A Review onPlants (Basel, Switzerland) · 2026
    Review
  3. Protective effect ofNagoya journal of medical science · 2024
    Article
  4. Article
  5. β-carotene regulates cancer stemness in colon cancerNutrition research and practice · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Nagoya journal of medical science · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Medicinal Plants in the Prevention and Treatment of Colon Cancer.Oxidative medicine and cellular longevity · 2019
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Soo Jin MinDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 120-750, Korea. 009267@naver.com.
Ji Ye LimDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 120-750, Korea. godlovesme86@hanmail.net.
Haeng Ran KimNational Academy of Agricultural Science, Rural Development Administration, Jeollabuk-do 565-851, Korea. kimhrr@korea.kr.
Se-Jae KimDepartment of Biology, Jeju National University, Jejusi, Jeju 690-756, Korea. jejusasa@naver.com.
Yuri KimDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 120-750, Korea. yuri.kim@ewha.ac.kr.
Ewha Womans University · KRJeju National University · KRRural Development Administration · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rare subpopulation of cancer cells, termed cancer stem cells (CSCs), may be responsible for tumor relapse and resistance to conventional chemotherapy. The development of a non-toxic, natural treatment for the elimination of CSCs is considered a strategy for cancer treatment with minimal side effects. In the present study, the potential for Sasa quelpaertensis leaf extract (SQE) and its two bioactive compounds, tricin and p-coumaric acid, to exert anti-CSC effects by suppressing cancer stemness characteristics were evaluated in colon cancer cells. CD133+CD44+ cells were isolated from HT29 and HCT116 cell lines using flow-activated cell sorting (FACs). SQE treatment was found to significantly suppress the self-renewal capacity of both cell lines. SQE treatment was also associated with the down-regulation of β-catenin and phosphorylated GSK3β, while significantly enhancing cell differentiation by up-regulating CK20 expression and blocking the expression of several stem cell markers, including DLK1, Notch1, and Sox-2. In vivo, SQE supplementation suppressed tumor growth in a xenograft model by down-regulating stem cell markers and β-catenin as well as HIF-1α signaling. Compared with two bioactive compounds of SQE, SQE exhibited the most effective anti-CSC properties. Taken together, these results provide evidence that SQE inhibits colon cancer by regulating the characteristics of CSCs.

Indexed as

AC133 AntigenAnimalsAntigens, CDAntineoplastic Agentsbeta CateninCalcium-Binding ProteinsColonic NeoplasmsFemaleGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGlycoproteinsHT29 CellsHumansHyaluronan ReceptorsHypoxia-Inducible Factor 1, alpha SubunitIntercellular Signaling Peptides and ProteinsAC133 AntigenAntigens, CDAntineoplastic Agentsbeta CateninCalcium-Binding ProteinsDLK1 protein, humanGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGlycoproteinsGSK3B protein, humanGsk3b protein, mouseHyaluronan ReceptorsHypoxia-Inducible Factor 1, alpha SubunitIntercellular Signaling Peptides and ProteinsMembrane ProteinsPeptidesPlant ExtractsPROM1 protein, humanProm1 protein, mouseReceptor, Notch1SOXB1 Transcription Factors

Identifiers

PMID25941936
PMCPMC4463628
OpenAlexW2154130599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.